TRAILR1/TNFRSF10A Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-56818
Key Product Details
Species Reactivity
Human
Applications
Immunocytochemistry/ Immunofluorescence
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was developed against a recombinant protein corresponding to the following amino acid sequence: ATPSKVWGSSAGRIEPRGGGRGALPTSMGQHGPSA
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for TRAILR1/TNFRSF10A Antibody
Immunocytochemistry/ Immunofluorescence: TRAILR1/TNFRSF10A Antibody [NBP2-56818]
Immunocytochemistry/Immunofluorescence: TRAIL R1/TNFRSF10A Antibody [NBP2-56818] - Staining of human cell line A-431 shows localization to nucleoplasm.Applications for TRAILR1/TNFRSF10A Antibody
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
0.25-2 ug/ml
Application Notes
Immunocytochemistry/Immunofluorescence Fixation Permeabilization: Use PFA/Triton X-100.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS (pH 7.2) and 40% Glycerol
Preservative
0.02% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: TRAILR1/TNFRSF10A
Long Name
TRAIL Receptor 1
Alternate Names
CD261, DR4, TNFRSF10A, TRAIL R1
Gene Symbol
TNFRSF10A
Additional TRAILR1/TNFRSF10A Products
Product Documents for TRAILR1/TNFRSF10A Antibody
Product Specific Notices for TRAILR1/TNFRSF10A Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...